-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731.O3.6 731. Clinical Autologous Transplantation: Results III

Clinical Autologous Transplantation: Results Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 6:15 PM-7:45 PM
W314, Level 3 (Orange County Convention Center)
Moderators:
Sonali Smith, University of Chicago and Corrado Tarella, MD, Division of Hematoncology

Disclosures:
Smith: Genentech: Consultancy ; Celgene: Consultancy ; Seattle Genetics: Consultancy ; PHarmacyclics: Consultancy ; Juno: Consultancy ; Gilead: Consultancy .
6:15 PM

Jessica Sun, MD1, Mohamad Mikati, MD2*, Jesse Troy, PhD1*, Kathryn Gustafson, PhD3*, Ryan Simmons, MS1*, Ricki Goldstein, MD4*, Jodi Petry, MS, OTR/L5*, Colleen McLaughlin, DNP1*, Barbara Waters-Pick, BS, MT(ASCP)6*, Laura Case, PT, DPT7*, Gordon Worley, MD2* and Joanne Kurtzberg, MD1

1CT2, DTMI, Duke University, Durham, NC
2Pediatric Neurology, Duke University, Durham, NC
3Department of Psychiatry, Duke University, Durham, NC
4Neonatology, Duke University, Durham, NC
5Department of Occupational Therapy, Duke University, Durham, NC
6Stem Cell Laboratory, Duke University, Durham, NC
7Department of Physical Therapy, Duke University, Durham, NC

6:30 PM

Norbert Claude Gorin, Pr, MD, PhD1, Myriam Labopin, MD2*, Tomasz Czerw, MD3*, Kurt Leibundgut, MD4, Didier Blaise, MD, PhD5, Pierre Yves Dumas, MD, PhD6, Damir Nemet, MD, PhD7, William Arcese, MD8, Roberto Foa, M.D.9*, Wu Depei, MD10*, Anne Huynh, MD11*, Tsila Zuckerman, MD12*, Ellen Meijer, MD PhD13, Seckin Cagirgan, PhD, MD14*, Jan Cornelissen, MD, PhD15, Mohamad Mohty, MD, PhD16 and Arnon Nagler, MD, MSc17

1Hematology-cell therapy and EBMT, Hopital Saint-Antoine and Universite Pierre et Marie Curie UPMC, Paris, France
2Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
3Institute of Oncology, Maria Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland
4Paediatric Hematology, University hospital, Bern, Switzerland
5Programme de Transplantation et Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
6hematology, University Hospital of Bordeaux, Pessac, France
7Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia
8Stem Cell Transplant Unit, University Tor Vergata, Rome, Italy
9Hematology, Sapienza University, Rome, Italy
10Hematology, First affiliated hospital of Soochow university, suzhou, China
11Institut Universitaire du cancer, Oncopole IUCT, Toulouse, France
12Hematology and BMT, Rambam medical center, Haifa, Israel
13Hematology, VU University Medical Center, Amsterdam, Netherlands
14Hematology, Ege University Medical School, Izmir, Turkey
15Department of Hematology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, Netherlands
16Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
17EBMT Acute Leukemia Working Party and Registry, Hematology Division, BMT and Cord Blood Bank, Tel-Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Ramat- Gan, Israel

6:45 PM

Roberto Mina1*, Alessandra Larocca1*, Massimo Offidani2, Sara Bringhen1*, Tommaso Caravita2*, Valeria Magarotto, MD1*, Lucia Pantani, MD2*, Francesco Di Raimondo2, Alberto Bosi2, Iolanda D. Vincelli2*, Paola Tacchetti, MD2*, Gianluca Gaidano2, Sonia Grandi1*, Caterina Musolino2*, Chiara Cerrato1*, Ludek Pour3*, Monica Astolfi1*, Giuseppe Rossi, MD2, Fausto Rossini2*, Maria T. Petrucci2*, Roberto Ria2*, Annalisa Pezzi, PhD2*, Roman Hajek4, Michele Cavo2*, Andrew Spencer5, Mario Boccadoro, MD1 and Antonio Palumbo1

1Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
2Italian Multiple Myeloma Network, GIMEMA, Italy
3University Hospital Brno and Faculty of Medicine MU, Brno, Czech Republic
4Dept. of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
5Myeloma Research Group, ACBD, Alfred Health-Monash University, Melbourne, Australia

7:00 PM

Chezi Ganzel1*, Vikram Mathews, DM2, Kamran Alimoghaddam, MD3, Ardeshir Ghavamzadeh, MD3, Deborah Kuk, ScM4*, Sean Devlin, PhD4*, Hailin Wang5*, Daniel Weisdorf, MD6, Dan Douer, MD7, Jacob M. Rowe, MD1,8, Arnon Nagler, MD, MSc9, Mohamad Mohty10, Martin S. Tallman, MD11, Jordi Estev12* and Mei-Jie Zhang13*

1Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
2Department of Haematology, Christian Medical College, Vellore, India
3Shariati Hospital, Tehran, Iran
4Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
5CIBMTR Statistical Center, Minneapoiis
6Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
7Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
9Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel
10Saint-Antoine Hospital and University Pierre & Marie Curie, Paris, France
11Memorial Sloan-Kettering Cancer Center, New York, NY
12Hospital Clinic, Institut d' investigacions biomediques August Pi Sunyer, Barcelona, Spain
13Medical College of Wisconsin, Milwaukee

7:15 PM

Nina Shah, MD1, Li Li, MD2*, Indreshpal Kaur, PhD3*, Jessica McCarty4*, Eric Yvon, PhD1*, Hila Shaim, MD1*, Muharrem Muftuoglu1*, Enli Liu, MD, MS1*, Catherine Sobieski1*, Robert Z. Orlowski, Ph.D., M.D.5, Laurence J.N. Cooper, MD, PhD6, Dean A. Lee, MD, PhD7, Simrit Parmar, MD1, Kai Cao, MS, MD8*, Chitra M. Hosing, MD1, Sairah Ahmed, MD1, Yago Nieto, MD, PhD1, Qaiser Bashir, MD1, Krina K Patel1, Catherine M. Bollard, MD9,10, Ian K. McNiece, PhD11, Muzaffar Qazilbash, M.D.1, Richard E. Champlin, MD1, Katayoun Rezvani1 and Elizabeth J. Shpall, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3The University of Texas M. D. Anderson Cancer Center, Houston, TX
4MD Anderson Cancer Center, HOUSTON, TX
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
6Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
7Pediatric Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX
8Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
9Children's National Health System, Washington, DC
10The George Washington University, Washington, DC
11The University of Texas MD Anderson Cancer Center, Houston, TX

7:30 PM

Leslie Popplewell**, MD1, Xiuli Wang**, PhD1, Araceli Naranjo, BS1*, Suzette Blanchard, PhD2*, Jamie Wagner, BS1*, ChingLam Wong, BS1*, Ryan Urak, MS1*, Wen-Chung Chang, MS1*, Samer K Khaled, MD3, Tanya Siddiqi, MD1, Elizabeth E. Budde, MD, PhD1, Jingying Xu, PhD1*, Brenda Chang, BS1*, Sandra H. Thomas, PhD1, Stanley R. Riddell, MD4*, Christine Brown, PhD1*, Michael C Jensen***, MD5* and Stephen J. Forman***, MD1

1Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Department of Information Sciences, City of Hope National Medical Center, Duarte, CA
3City of Hope, Duarte, CA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA

*signifies non-member of ASH